Srinagar Magazine

Chronic Fatigue Syndrome Market to Observe Impressive Growth | Key Companies – AIM Immuno Technology, Cortene Therapeutics, NL5 Pharmaceuticals

 Breaking News
  • No posts were found

Chronic Fatigue Syndrome Market to Observe Impressive Growth | Key Companies – AIM Immuno Technology, Cortene Therapeutics, NL5 Pharmaceuticals

April 28
00:24 2023
Chronic Fatigue Syndrome Market to Observe Impressive Growth | Key Companies - AIM Immuno Technology, Cortene Therapeutics, NL5 Pharmaceuticals
DelveInsight Business Research LLP
DelveInsight’s “Chronic Fatigue Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Chronic Fatigue Syndrome, historical and forecasted epidemiology as well as the Chronic Fatigue Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Chronic Fatigue Syndrome Market Insights, Epidemiology, and Market Forecast-2032  report delivers an in-depth understanding of the Chronic Fatigue Syndrome, historical and forecasted epidemiology as well as the Chronic Fatigue Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

 

Chronic Fatigue Syndrome Overview

Chronic Fatigue Syndrome (ME/CFS) is a chronic, debilitating multi-system illness affecting the neurological, endocrine, and immune systems characterized by profound fatigue, sleep abnormalities, pain and other symptoms that are made worse by exertion. It is suspected that the disease is caused by a change in the immune system of the person and the way the patient responds to infection or stress, viral infection, psychological stress, genetics or a combination of factors. ME/CFS shares some features of autoimmune illnesses as well. Symptoms may appear similar to other illnesses and there is no test to confirm ME/CFS, making it difficult to diagnose. The illness can be unpredictable. Symptoms come and go, or there may be changes in the severity over time. Primary symptoms include highly reduced ability to do activities that were usual before the illness. This drop in activity level occurs along with fatigue and lasts for six months or longer, with worsening of symptoms after physical or mental activity that would not have caused a problem before illness known as post-exertional malaise (PEM) and sleep problems.

 

Chronic Fatigue Syndrome Epidemiology Insights:

  • According to a major study conducted by Valdez et al. (2019) in a study titled “Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning”, the frequency of diagnosi

  • s of ME/CFS was 519–1,038/1,00,000 and among theses diagnosed patients 35-40% were men. Additionally, the study also highlighted the fact that  the number of patients who may be diagnosed with the disease in the US is approximately 1.7 million to 3.38 million.

  • The Centers for Disease Control and Prevention (CDC) conducted a ME/CFS surveillance study and estimated that between 8,36,000 and 2.5 million Americans have been estimated to have ME/CFS. However, among these identified cases, less than 20% received a proper ME/CFS diagnosis and among persons diagnosed with the condition, the ratio of women to men can be as high as 4 to 1. Moreover, the study mentioned that the disease is less common in children than in adults, and it is more prevalent in adolescents than in younger children. It is most common in people between 40 and 60 years old.

 Click here to learn more about Chronic Fatigue Syndrome Market Landscape

The Report Covers the Chronic Fatigue Syndrome Epidemiology Segmented by –

  • Chronic Fatigue Syndrome total prevalent cases 

  • Chronic Fatigue Syndrome gender specific prevalent cases 

  • Chronic Fatigue Syndrome age specific prevalent cases 

  • Chronic Fatigue Syndrome treated cases 

  • Chronic Fatigue Syndrome diagnosed cases 

Chronic Fatigue Syndrome Market Outlook 

The Chronic Fatigue Syndrome market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Chronic Fatigue Syndrome market trends by analyzing the impact of current Chronic Fatigue Syndrome therapies on the market, unmet needs, drivers and barriers, and demand for better technology.This segment gives a thorough detail of Chronic Fatigue Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Chronic Fatigue Syndrome market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Chronic Fatigue Syndrome market in 7MM is expected to witness a major change in the study period 2019-2032.

 Key Companies in the Chronic Fatigue Syndrome Market Include:

  • AIM Immuno Technology 

  • Cortene Therapeutics 

  • NL5 Pharmaceuticals 

And many more 

Chronic Fatigue Syndrome Therapies Covered in the Report Include:

  • Ampligen 

  • CT38

  • NLS-4 (Lauflumide)

And many others

Learn more about the Key Companies and the Emerging Therapies in the Chronic Fatigue Syndrome Market

Table of Contents 

  1. Key Insights 

  2. Report Introduction 

  3. Executive Summary of Chronic Fatigue Syndrome  

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Chronic Fatigue Syndrome Emerging Therapies

  7. Chronic Fatigue Syndrome Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Click here to read more about the report’s offerings @ Chronic Fatigue Syndrome Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services